Role of copper gluconate/triethanolamine in irinotecan encapsulation inside the liposomes

International Journal of Pharmaceutics

Volumn 337, Issue 1-2, 2007, Pages 219-228

  Dicko, Awa ^a   Tardi, Paul ^a   Xie, Xiaowei ^a   Mayer, Lawrence ^a  

^a Celator Pharmaceuticals Corp   (Canada)

Author keywords

Copper gluconate; Irinotecan; Liposomes; Spectroscopy; Triethanolamine

Indexed keywords

GLUCONATE COPPER; GLUCONATE COPPER PLUS TRIETHANOLAMINE; HYDROXYL GROUP; IRINOTECAN; LIPOSOME; TRIETHANOLAMINE; UNCLASSIFIED DRUG;

ARTICLE; CIRCULAR DICHROISM; COMPLEX FORMATION; DRUG RETENTION; ENCAPSULATION; FLUORESCENCE; HYDROGEN BOND; INFRARED SPECTROSCOPY; PRIORITY JOURNAL; SPECTROSCOPY; STOICHIOMETRY;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CAMPTOTHECIN; CHEMISTRY, PHARMACEUTICAL; CIRCULAR DICHROISM; DRUG COMPOUNDING; ETHANOLAMINES; GLUCONATES; HYDROGEN BONDING; HYDROGEN-ION CONCENTRATION; KINETICS; LIPOSOMES; SOLUBILITY; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY, ULTRAVIOLET; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TECHNOLOGY, PHARMACEUTICAL; TEMPERATURE;

EID: 34248586310     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.01.004     Document Type: Article

References (37)

1. Aiyama R., Nagai H., Sawasa S., Yokokura T., Itokawa H., and Nakanishi M. Determination of self-association of irinotecan hydrochloride (CPT-11) in aqueous solution. Chem. Pharm. Bull. 40 (1992) 2810-2813
2. Almgren M., Edwards K., and Karlsson G. Cryo transmission electron microscopy of liposomes and related structures. Colloids Surf. A: Physicochem. Eng. Aspects 174 (2000) 3-21
3. Bally M.B., Hope M.J., Mayer L.D., Madden T.D., and Cullis P.R. Novel procedures for generating and loading liposomal systems. In: Gregoriadis G. (Ed). Liposomes as Drug Carriers (1988), John Wiley & Sons Ltd. 841-853
4. Barenholz Y., Amselem S., Goren D., Cohen R., Gelvan D., Samuni A., Golden E.B., and Gabizon A. Stability of liposomal doxorubicin formulations: problems and prospects. Med. Res. Rev. 13 (1993) 449-491
5. Batist G., Chi K., Miller W., Chia S., Hasanbasic F., Fisic A., Mayer L.M., Swenson C., Janoff A., and Gelmon K. Phase I study of CPX-1, a fixed ratio formulation of irinotecan (Iri) and floxuridine (Flox), in patients with advanced solid tumors. Proceedings of the 2006 ASCO Annual Meeting (2006) (Abstract No. 2014)
6. 13C{double bond, long}O-labeled phospholipids hydrogen bonding to carbonyl groups. Biochemistry 27 (1988) 8239-8249
7. Boman N.L., Mayer L.D., and Cullis P.R. Optimization of the retention properties of vincristine in liposomal systems. Biochim. Biophys. Acta 1152 (1993) 253-258
8. Brezova V., Valko M., Breza M., Morris H., Telser J.m., Dvoranova D., Kaiserova K., Varecka L., Mazur M., and Leibfritz D. Role of radicals and singlet oxygen in photoactivated DNA cleavage by the anticancer drug camptothecin: an electron paramagnetic resonance study. J. Phys. Chem. B 107 (2003) 2415-2425
9. Burke T.G., Mishra A.K., Wani M.C., and Wall M.E. Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry 32 (1993) 5352-5364
10. 2+-drug complexes. Biochim. Biophys. Acta 1414 (1998) 204-216
11. Chourpa I., Millot J.-M., Sockalingum G.D., Riou J.-F., and Manfait M. Kinetics of lactone hydrolysis in antitumor drugs of camptothecin series as studied by fluorescence spectroscopy. Biochim. Biophys. Acta 1379 (1998) 353-366
12. Conley B.A., Egorin M.J., Whitacre M.Y., Carter D.C., Zuhowski E.G., and Van Echo D.A. Phase I and pharmacokinetic trial of liposome-encapsulated doxorubicin. Cancer Chemother. Pharmacol. 33 (1993) 107-112
13. Cullis P.R., Bally M.B., Madden T.D., Mayer L.D., and Hope M.J. pH gradients and membrane transport in liposomal systems. Tibtech. 9 (1991) 57-61
14. Cullis P.R., Hope M.J., Bally M.B., Madden T.D., Mayer L.D., and Fenske D.B. Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles. Biochim. Biophys. Acta 1331 (1997) 187-211
15. Drummond D.C., Noble C.O., Guo Z., Hong K., Park J.W., and Kirpotin D.B. Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy. Cancer Res. 66 (2006) 2171-3277
16. Escandar G.M., and Sala L.F. Complexes of Cu(II) with d-aldonic and d-alduronic acids in aqueous solution. Can. J. Chem. 70 (1992) 2053-2057
17. Feng M., Yang Y., He P., and Fang Y. Spectroscopic studies of copper(II) and iron(II) complexes of adriamycin. Spectrochim. Acta A 56 (2000) 581-587
18. Foye W.O. Role of metal-binding in the biological activities of drugs. J. Pharm. Sci. 50 (1961) 93-108
19. Gajda T., Gyurcsik B., Jakusch T., Burger K., Henry B., and Delpuech J.-J. Coordination chemistry of polyhydroxy acids: role of the hydroxyl groups. Inorg. Chim. Acta 275-276 (1998) 130-140
20. Gelmon K.A., Tolcher A., Diab A.R., Bally M.B., Embree L., Hudon N., Dedhar C., Ayers D., Eisen A., Melosky B., Burge C., Logan P., and Mayer L.D. Phase I study of liposomal vincristine. J. Clin. Oncol. 17 (1999) 697-705
21. Greenaway F.T., and Dabrowiack J.C. The binding of copper ions to daunomycin and adriamycin. J. Inorg. Biochem. 16 (1982) 91-107
22. Grit M., and Crommelin D.J. Chemical stability of liposomes: implications for their physical stability. Chem. Phys. Lipids 64 (1993) 3-18
23. Haran G., Cohen R., Bar L.K., and Barenholz Y. Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases. Biochim. Biophys. Acta 1151 (1993) 201-215
24. Huang S.K., Mayhew E., Gilani S., Lasic D.D., Martin F.J., and Papahadjopoulos D. Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon carcinoma. Cancer Res. 52 (1992) 6774-6781
25. Kuwahara J., Suzuki T., Funakoshi F., and Sugiura Y. Photosensitive DNA cleavage and phage inactivation by copper(II)-camptothecin. Biochemistry 25 (1986) 1216-1221
26. Madden T.D., Harrigan P.R., Tai L.C.L., Bally M.B., Mayer L.D., Redelmeier T.E., Loughrey H.C., Tilcock C.P.S., Reinish L.W., and Cullis P.R. The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey. Chem. Phys. Lipids 53 (1990) 37-46
27. Mayer L.D., Bally M.B., Hope M.J., and Cullis P.R. Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential. Biochim. Biophys. Acta 813 (1985) 294-302
28. Mayer L.D., Tai L.C.L., Ko D.S.C., Masin D., Ginsberg R.S., Cullis P.R., and Bally M.B. Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice. Cancer Res. 49 (1989) 5922-5930
29. Mayer L.D., Harasym T.O., Tardi P.G., Harasym N.L., Shew C.R., Johnstone S.A., Ramsay E.C., Bally M.B., and Janoff A.S. Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration dictates therapeutic activity in tumor-bearing mice. Mol. Cancer Ther. 5 (2006) 1854-1863
30. Nabiev I., Fleury F., Kudelina I., Pommier Y., Charton F., Riou J.-F., Alix A.J., and Manfait M. Spectroscopic and biochemical characterization of self-aggregates formed by antitumor drugs of the camptothecin family. Biochem. Pharmacol. 55 (1998) 1163-1174
31. Noble C.O., Krauze M.T., Drummond D.C., Yamashita Y., Saito R., Berger M.S., Kirpotin D.B., Bankiewicz K.S., and Park J.W. Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res. 66 (2006) 2801-2806
32. Ramsay E., Alnajim J., Anantha M., Dicko A., Harvie P., Mayer L.D., Bally M.B., and Tardi P. A novel approach to prepare a liposomal irinotecan formulation that exhibit significant therapeutic activity in vivo. Proc. Annu. Meet. Am. Assoc. Cancer Res. 45 (2004) (abstract #639)
33. Silverstein R.M., Bassler G.C., and Morrill T.C. Spectrometric Identification of Organic Compounds. 5th ed. (1991), John Wiley & Sons, NY pp. 91-142
34. Tachibana M., Iwaizumi M., and Tero-Kubota S. EPR studies of copper(II) and cobalt(II) complexes of adriamycin. J. Inorg. Biochem. 30 (1987) 133-140
35. Tardi, P.G., Gallagher, R.C., Johnson, S., Harasym, N., Webb, M., Bally, M.B., Mayer, L.D., in press. Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo. Biochim. Biophys. Acta.
36. 3N,O,O′)copper(II) squarate. Acta Crystallogr. E60 (2004) m322-m324
37. Viles J.H., Cohen F.E., Prusiner S.B., Goodin D.B., Wright P.E., and Dyson H.J. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 2042-2047